C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment

Eur Neuropsychopharmacol. 1990 Nov;1(1):51-4. doi: 10.1016/0924-977x(90)90011-x.

Abstract

A multi-lead C-EEG investigation was carried out, in order to evaluate changes induced by acute and chronic treatment with haloperidol in DSM-III-R schizophrenics. After the acute treatment the main C-EEG changes were (1) a significant decrease of delta relative power (RP) over all the explored leads and of theta 1 over the occipital leads; (2) an increase in alpha 2 and beta 2 RP, as well as a decrease of beta 3 RP confined to the anterior temporal leads (T3, T4). During chronic treatment, C-EEG changes observed were (1) a significant decrease of delta RP and an increase of theta 1 RP; (2) an increase of alpha 1 and alpha 2 RP; (3) a significant decrease of beta 1, beta 2 and beta 3.

MeSH terms

  • Adult
  • Brain Mapping*
  • Electroencephalography*
  • Female
  • Haloperidol / therapeutic use*
  • Humans
  • Male
  • Psychiatric Status Rating Scales
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology

Substances

  • Haloperidol